When
Where
Register here to join virtually
Event Description
The practice and delivery of health care is changing with an emphasis on improving quality, safety, efficiency and access to care. Telemedicine can help you achieve these goals! The Arizona Telemedicine Program and Southwest Telehealth Resource Center invite you to a free one-hour CME webinar on the implementation and practice of telemedicine.
Telehealth and the future of professional regulation
This introduction to Software as a Medical Device or SAMD will orient you to the concepts, current regulations and the AMA’s as well as a few specialty organizations’ thoughts on its usage.
This webinar is made possible through funding provided by Health Resources and Services Administration, Office for the Advancement of Telehealth (U1U42527).
Presenter Details
Carol Yarbrough, MBA, CCA, CPC, PCS, CHC
National Billing Expert
Yarbrough is a specialist in Federal and State regulatory billing and reimbursement guidelines. Holding certificates in hospital and professional fee, ophthalmic and clinical compliance she provides us with the rest of the story. You know her as our inside scooper on telehealth and other virtual care policies, updates and the next new things.
Outcome objectives
- List FDA definitions vs. approvals: When does either apply/approval process.
- Name two regulations and examples in use today.
- Describe the future of SAMD and how to envision its use in clinical practice.
Accreditation statement
The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure statement
All Faculty, CME Planning Committee Members and the CME Office Reviewers have disclosed that they do not have any relevant financial relationships with ineligible companies that could constitute a conflict of interest concerning this CME activity.